Science, Policy, Biotech Thomas Culman Science, Policy, Biotech Thomas Culman

Managing pain without opioids is on the horizon – if we decide it’s worth it

Thanks to the relentless efforts of scientists at Vertex Pharmaceuticals, there will likely soon be a novel non-opioid pain medicine. How insurance plans, including Medicare, decide to cover this drug will make a world of difference to whether we get even better non-opioid options down the road — and whether this progress makes a dent in the ongoing opioid misuse crisis.

Read More